DCAF7 抗体 (N-Term)
Quick Overview for DCAF7 抗体 (N-Term) (ABIN928603)
抗原
See all DCAF7 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
交叉反应
- 小鼠
-
纯化方法
- Purified
-
免疫原
- Dcaf7 antibody was raised in rabbit using the N terminal of Dcaf7 as the immunogen
-
-
-
-
应用备注
- Optimal conditions should be determined by the investigator.
-
说明
-
Dcaf7 Blocking Peptide, (ABIN5613131), is also available for use as a blocking control in assays to test for specificity of this Dcaf7 antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- Lot specific
-
缓冲液
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))
-
别名
- Dcaf7
-
背景
- Dcaf7 is involved in craniofacial development. It acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches. It associates with DIAPH1 and controls GLI1 transcriptional activity. It could be involved in skin development. It may function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. Synonyms: Polyclonal Dcaf7 antibody, Anti-Dcaf7 antibody, DDB1 and CUL4 associated factor 7 antibody, 1700012F10Rik antibody, 2610037L01Rik antibody, C86529 antibody, HAN11 antibody, Wdr68 antibody.
-
途径
- SARS-CoV-2 Protein Interactome
抗原
-